Pharmacies receiving massive rebates from generic drug-makers.
作者信息
Silversides Ann
出版信息
CMAJ. 2006 Aug 15;175(4):342. doi: 10.1503/cmaj.060904.
Abstract
摘要
相似文献
1
Pharmacies receiving massive rebates from generic drug-makers.从仿制药制造商那里获得巨额回扣的药店。
CMAJ. 2006 Aug 15;175(4):342. doi: 10.1503/cmaj.060904.
2
Generics offer pharmacy plans specific benefits.仿制药为药房计划带来了特定的益处。
Manag Care. 2010 Feb;19(2):28-30, 34.
3
Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?法国非专利药品的药房折扣：是否还有进一步提高效率节省成本的空间？
Curr Med Res Opin. 2007 Oct;23(10):2467-76. doi: 10.1185/030079907X219571.
4
Effect of generic drug competition on the price of prescription drugs in Ontario.仿制药竞争对安大略省处方药价格的影响。
CMAJ. 1993 Jan 1;148(1):35-8.
5
Generic drugs: shop around for the best deals.通用药物：多方比较以获取最优惠价格。
Consum Rep. 2006 Nov;71(11):58-9.
6
[Parallel import of drugs for better and for worse].[药品平行进口的利弊]
Ugeskr Laeger. 2004 Feb 9;166(7):611.
7
8
Rx: Canadian drugs.处方：加拿大药品。
N Engl J Med. 2004 Mar 11;350(11):1155. doi: 10.1056/NEJM200403113501119.
9
Pharmaceuticals and Medical Devices: Cost Savings.药品和医疗器械：成本节约。
Issue Brief Health Policy Track Serv. 2017 Dec 26;2017:1-31.
10
The importance of being first: evidence from Canadian generic pharmaceuticals.先发优势：来自加拿大非专利药品的证据
Health Econ. 2002 Dec;11(8):723-34. doi: 10.1002/hec.698.
引用本文的文献
1
Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review.优化患有多种药物和多种疾病的老年人用药的干预措施的经济评估：系统评价。
Clin Interv Aging. 2021 May 5;16:767-779. doi: 10.2147/CIA.S304074. eCollection 2021.
2
How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?欧洲的药剂师薪酬体系如何促进仿制药的配药？
Pharm Pract (Granada). 2012 Jan;10(1):3-8. doi: 10.4321/s1886-36552012000100002. Epub 2012 Mar 31.
3
Moving from opacity to transparency in pharmaceutical policy.推动药品政策从不透明走向透明。
CMAJ. 2008 Feb 12;178(4):428-31. doi: 10.1503/cmaj.070799.
Zotero 插件